Client of Farmavita.Net is looking for EU CTD Dossier with bulk supply of 40mg/80mg tablets of drotaverin hydrochloride.
License territory would be Poland. Licensee is established company with well developed sales and distribution capability.
Drotaverine (INN, also known as drotaverin) is an antispasmodic drug, structurally related to papaverine. Drotaverine is a selective inhibitor of phosphodiesterase 4, and has no anticholinergic effects. A small 2003 study found drotaverine to be nearly 80% effective in treating renal colics. It has also been used to accelerate labor.
Forecast of sales is:
|2010 ||2011 ||2012 ||2013 ||2014 |
|40mg@20tbs ||300.000||450.000||670.000 ||850.000||1.000.000 |
|80mg@20tbs||60.000 ||130.000 ||200.000 ||250.000||320.000|
Please, contact us for more details about this business opportunity.
|Pharma licensing||In-licensing (demand)|